Legal Representation
Attorney
Steven A. Fleckman
USPTO Deadlines
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 26, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 5, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 4, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 4, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 28, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 11, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 11, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 24, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 22, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 22, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 22, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 9, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 26, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 24, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 24, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 24, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 27, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 25, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 25, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 25, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 26, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 31, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 31, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 11, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 20, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 19, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 19, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 19, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 2, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 2, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 2, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 29, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 17, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 16, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 15, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research and development services and consultation related thereto in the field of substance abuse and opioid addiction
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the literal element "Mµ" in stylized font positioned above the word "THERAPEUTICS," with the "I" in "THERAPEUTICS" positioned within the descending left line of the character "µ," and a stylized representation of a molecular structure positioned above the character "µ," all positioned within a design of a parallelogram with rounded top left and bottom right corners and a gradation from dark shading in the bottom left corner to light shading in the top right corner.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"Mµ THERAPEUTICS"